tradmap

SBRA Earnings Sabra Health Care Reit, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$1 $0 $2 $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $178M $357M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$113M $83M $279M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$0 $0 $0 $0 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
EPS
Revenue (quarterly)
$0 $72M $143M Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue
Net income (quarterly)
-$25M $20M $66M $0 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Net income

Reported EPS history

1–60 of 60
Q3 20262026-09-300.112026-11-0210-Q
Q2 20262026-06-30-0.102026-08-0310-Q
Q1 20262026-03-310.162026-04-2910-Q
Q4 2025 (derived)2025-12-310.112026-02-1210-K
FY 20252025-12-310.642026-02-1210-K
Q3 20252025-09-300.092025-11-0510-Q
Q2 20252025-06-300.272025-08-0410-Q
Q1 20252025-03-310.172025-05-0510-Q
Q4 2024 (derived)2024-12-310.202025-02-1910-K
FY 20242024-12-310.542025-02-1910-K
Q3 20242024-09-300.132024-10-3110-Q
Q2 20242024-06-300.102024-08-0710-Q
Q1 20242024-03-310.112024-05-0810-Q
Q4 2023 (derived)2023-12-310.082024-02-2710-K
FY 20232023-12-310.062024-02-2710-K
Q3 20232023-09-30-0.072023-11-0610-Q
Q2 20232023-06-300.092023-08-0710-Q
Q1 20232023-03-31-0.042023-05-0310-Q
Q4 2022 (derived)2022-12-31-0.372023-02-2110-K
FY 20222022-12-31-0.342023-02-2110-K
Q3 20222022-09-30-0.222022-11-0710-Q
Q2 20222022-06-300.072022-08-0310-Q
Q1 20222022-03-310.182022-05-0410-Q
Q4 2021 (derived)2021-12-31-0.122022-02-2210-K
FY 20212021-12-31-0.522022-02-2210-K
Q3 20212021-09-300.052021-11-0310-Q
Q2 20212021-06-30-0.612021-08-0410-Q
Q1 20212021-03-310.162021-05-0510-Q
Q4 2020 (derived)2020-12-310.182021-02-2210-K
FY 20202020-12-310.672021-02-2210-K
Q3 20202020-09-300.182020-11-0510-Q
Q2 20202020-06-300.142020-08-0510-Q
Q1 20202020-03-310.172020-05-0610-Q
Q4 2019 (derived)2019-12-310.232020-02-2410-K
FY 20192019-12-310.372020-02-2410-K
Q3 20192019-09-300.122019-10-3010-Q
Q2 20192019-06-300.462019-08-0710-Q
Q1 20192019-03-31-0.442019-05-0810-Q
Q4 2018 (derived)2018-12-31-0.112019-02-2510-K
FY 20182018-12-311.512019-02-2510-K
Q3 20182018-09-300.202018-11-0510-Q
Q2 20182018-06-301.082018-08-0810-Q
Q1 20182018-03-310.342018-05-0910-Q
Q4 2017 (derived)2017-12-310.772018-02-2110-K
FY 20172017-12-311.402018-02-2110-K
Q3 20172017-09-300.112017-11-0110-Q
Q2 20172017-06-300.272017-08-0210-Q
Q1 20172017-03-310.252017-05-0810-Q
Q4 2016 (derived)2016-12-310.322017-02-2210-K
FY 20162016-12-310.922017-02-2210-K
Q3 20162016-09-300.352016-11-0210-Q
Q2 20162016-06-300.532016-08-0110-Q
Q1 20162016-03-31-0.282016-05-0310-Q
Q4 2015 (derived)2015-12-310.352016-02-2210-K
FY 20152015-12-311.112016-02-2210-K
Q3 20152015-09-300.242015-11-0910-Q
Q2 20152015-06-300.242015-08-0410-Q
Q1 20152015-03-310.282015-05-0610-Q
Q4 2014 (derived)2014-12-310.442015-02-1910-K
FY 20142014-12-310.782015-02-1910-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.